Accelerated Pharma (Accelerated Pharma) Research & Development : $-0.07 Mil (TTM As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Accelerated Pharma's Research & Development for the three months ended in Mar. 2017 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.07 Mil.

Accelerated Pharma Research & Development Historical Data

The historical data trend for Accelerated Pharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Research & Development Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Research & Development

2.27

0.17

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Research & Development	Get a 7-Day Free Trial			0.23	0.16	0.01	-0.24	-

Accelerated Pharma Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07 Mil.

Accelerated Pharma (NAS:ACCP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Accelerated Pharma Research & Development Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines